Predicting the outcome of psoriasis treatment

Anthony Ormerod

doi:10.1111/bjd.21747

Predicting the outcome of psoriasis treatment

Anthony Ormerod^* (Corresponding Author)

^*Corresponding author for this work

Applied Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Biomarker research embraces many disciplines, using advances in high-throughput molecular biology and computers to measure molecules directly involved in the disease process. Importantly, translational medicine requires close collaboration between clinical researchers, to have accurate phenotypes and to be able to adjust for established prognostic factors. In practice, the predictors of biomarkers will need to be assessed alongside clinical phenotypic and demographic factors.

Original language	English
Pages (from-to)	458-459
Number of pages	2
Journal	British Journal of Dermatology
Volume	187
Issue number	4
Early online date	22 Jul 2022
DOIs	https://doi.org/10.1111/bjd.21747
Publication status	Published - 1 Oct 2022

Bibliographical note

Acknowledgments
I thank David Burden and Andrew Pink for valuable comments and suggestions.

Access to Document

10.1111/bjd.21747Licence: Unspecified

Cite this

@article{cc6834f2245a402687f7c17bceb46fe5,

title = "Predicting the outcome of psoriasis treatment",

abstract = "Biomarker research embraces many disciplines, using advances in high-throughput molecular biology and computers to measure molecules directly involved in the disease process. Importantly, translational medicine requires close collaboration between clinical researchers, to have accurate phenotypes and to be able to adjust for established prognostic factors. In practice, the predictors of biomarkers will need to be assessed alongside clinical phenotypic and demographic factors.",

author = "Anthony Ormerod",

note = "Acknowledgments I thank David Burden and Andrew Pink for valuable comments and suggestions.",

year = "2022",

month = oct,

day = "1",

doi = "10.1111/bjd.21747",

language = "English",

volume = "187",

pages = "458--459",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press (OUP)",

number = "4",

}

TY - JOUR

T1 - Predicting the outcome of psoriasis treatment

AU - Ormerod, Anthony

N1 - Acknowledgments I thank David Burden and Andrew Pink for valuable comments and suggestions.

PY - 2022/10/1

Y1 - 2022/10/1

N2 - Biomarker research embraces many disciplines, using advances in high-throughput molecular biology and computers to measure molecules directly involved in the disease process. Importantly, translational medicine requires close collaboration between clinical researchers, to have accurate phenotypes and to be able to adjust for established prognostic factors. In practice, the predictors of biomarkers will need to be assessed alongside clinical phenotypic and demographic factors.

AB - Biomarker research embraces many disciplines, using advances in high-throughput molecular biology and computers to measure molecules directly involved in the disease process. Importantly, translational medicine requires close collaboration between clinical researchers, to have accurate phenotypes and to be able to adjust for established prognostic factors. In practice, the predictors of biomarkers will need to be assessed alongside clinical phenotypic and demographic factors.

U2 - 10.1111/bjd.21747

DO - 10.1111/bjd.21747

M3 - Comment/debate

SN - 0007-0963

VL - 187

SP - 458

EP - 459

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 4

ER -

Predicting the outcome of psoriasis treatment

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this